Šalis: Australija
kalba: anglų
Šaltinis: Department of Health (Therapeutic Goods Administration)
Ginkgo biloba, Quantity: 50 mg (Equivalent: Ginkgo biloba, Qty 2.5 g; Equivalent: Ginkgolides and bilobalide, Qty 3 mg; Equivalent: Ginkgo flavonglycosides, Qty 12 mg)
Evergrowth Pty Ltd
Tablet, film coated
Excipient Ingredients: hypromellose; colloidal anhydrous silica; povidone; macrogol 400; calcium hydrogen phosphate dihydrate; magnesium stearate; microcrystalline cellulose; crospovidone; Carnauba Wax
Oral
Medicine Listed
Antioxidant/Reduce free radicals formed in the body ; Maintain/support healthy hearing ; Maintain/support general health and wellbeing ; Maintain/support healthy blood circulation ; Maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; Maintain/support blood capillary health ; Decrease/reduce/relieve aching/tired legs/leg heaviness associated with mild varicose veins ; Maintain/support mental concentration/focus/clarity ; Enhance/improve/promote/increase mental alertness/wakefulness ; Maintain/support memory/mental recall
Visual Identification: ; Container Type: Bottle
Licence status A
1999-11-04
TERTROXIN- Consumer Medicine Information Page 1 of 3 TERTROXIN _liothyronine sodium _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about TERTROXIN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking TERTROXIN against the benefits he/she expects it will have for you. ASK YOUR DOCTOR OR PHARMACIST IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT TERTROXIN IS USED FOR TERTROXIN contains “liothyronine” which is a naturally occurring thyroid hormone. It is used for treating: • disorders of thyroid deficiency or low thyroid levels in the body • coma or unconsciousness caused by severely low thyroid levels in the body • an overactive thyroid gland which occurs in thyrotoxicosis or Grave’s Disease, together with other medicines • a low thyroid level after treatment of thyrotoxicosis. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY TERTROXIN HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed TERTROXIN for another reason. This medicine is only available with a doctor’s prescription. There is no evidence that TERTROXIN is addictive. BEFORE YOU USE IT _WHEN YOU MUST NOT TAKE IT_ _ _ _ _ DO NOT TAKE TERTROXIN IF: • YOU HAVE AN ALLERGY TO TERTROXIN OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET • YOU HAVE ANGINA • YOU HAVE ANY OTHER HEART CONDITION • YOU HAVE AN UNTREATED ADRENAL GLAND CONDITION DO NOT TAKE TERTROXIN IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. DO NOT TAKE TERTROXIN IF THE EXPIRY DATE (EXP) PRINTED ON THE PACK HAS PASSED. If you take this medicine after the expiry date has passed, it may not work. IF YOU ARE NOT SURE WHETHER YOU SHOULD START TAKING TERTROXIN, CONTACT YOUR DOCTOR. _BEFORE YOU START TO TAKE IT_ TELL YOUR DOCTOR IF YOU HAVE ALLERGIES TO ANY OTHER FOODS, Perskaitykite visą dokumentą
1 AUSTRALIAN PRODUCT INFORMATION TERTROXIN (LIOTHYRONINE SODIUM) TABLET 1 NAME OF THE MEDICINE Liothyroinine sodium 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 microgram liothyronine sodium. The excipients include sodium chloride and lactose. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablet - white, uncoated, plain on one side and with a break line on the other. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Tertroxin is indicated in the treatment of: coma due to myxoedema; management of severe thyroid deficiency; hypothyroid states arising in treatment of thyrotoxicosis. Tertroxin may be preferred for treating severe and acute hypothyroid states because of its rapid and more potent effect but thyroxine sodium is normally the drug of choice for routine replacement therapy. Tertroxin can also be used therapeutically in the treatment of thyrotoxicosis as an adjunct to carbimazole in order to prevent sub-clinical hypothyroidism developing during treatment. 4.2 D OSE AND METHOD OF ADMINISTRATION In myxoedema unless an immediate effect is needed, it is best to begin with small doses, 10- 20 microgram every 8 hours, increasing by steps, if necessary, to a total daily dosage of 60 microgram administered in divided doses. This dosage usually suffices for maintenance, but for continuous maintenance it is generally considered that thyroxine is desirable, for its disadvantages in treating manifestations of hypometabolism are advantages where therapy has to be continuous throughout life. Treatment of myxoedema coma should be initiated under specialist supervision. Sixty microgram may be given by stomach tube, then 20 microgram every 8 hours, although it is more usual to start treatment with intravenous liothyronine. As therapy for thyrotoxicosis with carbimazole: In adults 20 microgram of liothyronine every 8 hours. For children and elderly patients it is suggested that the initial dosage should be 5 microgram daily. In children the daily dosage of Perskaitykite visą dokumentą